Swiss National Bank
CGON icon

Swiss National Bank’s CG Oncology CGON Stock Holding History

Swiss National Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71M Hold
84,400
– – ﹤0.01% 1288
2025
Q4 		$3.5M Buy
84,400
+3,100
+4% +$128K ﹤0.01% 1569
2025
Q3 		$3.27M Buy
81,300
+1,200
+1% +$34.9K ﹤0.01% 1583
2025
Q2 		$2.08M Sell
80,100
-1,000
-1% -$24.1K ﹤0.01% 1794
2025
Q1 		$1.99M Buy
81,100
+1,500
+2% +$42.2K ﹤0.01% 1773
2024
Q4 		$2.28M Buy
79,600
+47,000
+144% +$1.61M ﹤0.01% 1771
2024
Q3 		$1.23M Sell
32,600
-6,800
-17% -$238K ﹤0.01% 2123
2024
Q2 		$1.24M Buy
+39,400
New +$1.37M ﹤0.01% 2063

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Swiss National Bank's CGON Position: Q1 2026 in Review

Swiss National Bank held its CG Oncology (CGON) position steady in Q1 2026 at 84,400 shares worth $5.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Swiss National Bank first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Swiss National Bank held 84,400 shares of CG Oncology worth $5.71M as of Q1 2026.
  • Swiss National Bank left its CG Oncology share count unchanged in Q1 2026.
  • CG Oncology made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1288 holding.
  • Swiss National Bank first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.